With thanks to the following companies and institutions for their unconditional support of the ISoP 2025 Annual Meeting
Platinum Sponsor
African Union Development Agency
The mandate of AUDA-NEPAD is to: a) coordinate and execute priority regional and continental projects to promote regional integration towards the accelerated realisation of Agenda 2063; and b) strengthen capacity of African Union (AU) Member States and regional bodies, advance knowledge-based advisory support, undertake the full range of resource mobilisation and serve as the continent’s technical interface with all Africa’s development stakeholders and development partners.
The new AUDA-NEPAD mandate gives the organisation a wider role in terms of providing knowledge-based advisory support to AU Member States in the pursuit of their national development priorities. The core functions of the Agency are to:
- Incubate innovative programmes in various fields, including technology, research and development, knowledge management, and data analytics;
- Provide technical and implementation support to RECs and AU Member States in the development and execution of priority projects and programmes;
- Assist AU Member States and RECs to strengthen capacity in key areas such as food and nutrition, energy, water, infrastructure, information and communication technology and digital economy, natural resource governance, climate change and institutional and human capital development and innovation;
- Provide advisory support in the setting up and application of norms and standards in thematic priorities of the AU to accelerate regional integration;
- Provide technical backstopping to the AU in implementing policy recommendations at the continental, regional and national levels;
- Monitor and assess Africa’s development trends and progress with the view to achieve key continental and global goals for the purpose of technical reporting;
- Undertake, apply and disseminate research on policy development support for AU Member States;
- Coordinate, facilitate and promote cooperation with Africa’s strategic partners and stakeholders for effective resource mobilisation;
- Coordinate and facilitate partnership with stakeholders and African academia;
- Foster the cooperation in Africa with the private sector; and
- Coordinate between AU Specialised Agencies, Organs and other institutions to create an enabling and supportive environment for the achievement of the goals and priorities of Agenda 2063.
Further information on AUDA-NEPAD can be found on Who We Are | AUDA-NEPAD
230, 15th Road, Midrand, Gauteng, Johannesburg, 1685, South Africa | Tel +27 (0) 11 256 3600 | www.nepad.org
Diamond Sponsor
Pfizer Biopharmaceuticals Egypt LLC
Pfizer is one of the world’s leading biopharmaceutical companies. Our diversified health care portfolio includes some of the world’s best known and most prescribed medicines and vaccines. At Pfizer, we apply science and our global resources to bring therapies to people that help extend and improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time.
To learn more about Pfizer https://www.pfizer.com/
Uppsala Monitoring Centre
UMC was established in 1978 through an agreement between the World Health Organization (WHO) and the government of Sweden as a WHO Collaborating Centre for International Drug Monitoring. UMC is custodian of the WHO global database of adverse event reports for medicines and vaccines and strengthens global safety surveillance through science and innovation, signal monitoring, development of pharmacovigilance tools, standardisation with the WHODrug dictionary, and education and communication.
Gold Sponsors
AB Cube
Life Sciences Trusted Cloud Software
AB Cube is the developer of the most efficient drug safety database software for life sciences organizations – enabling effortless pharmacovigilance, materiovigilance, cosmetovigilance and nutrivigilance operations in one unified platform. Founded in 2006, Paris-based AB Cube pioneered the industry’s with the first SaaS vigilance application. Now with a presence in 43 countries and serving over 220 international clients, today pharmaceutical laboratories, CROs, academics and health authorities trust AB Cube’s best-in-class SafetyEasy® Suite to support their global Multivigilance needs at every scale.
AB Cube’s offering includes our intuitive SafetyEasy® Suite, a software composed of three solutions:
- IntakeEasy: A suite of automated Modules for Data Capture.
- SafetyEasy® Vigilance: A Multivigilance solution for Data Management.
- SafetyEasy® Business Intelligence: A dynamic scientific Data Analytics solution.
Beyond software, AB Cube provides a range of expert services, including training, quality & validation, project management, technical assistance and migration. This comprehensive support ensures that our partners can maximize the benefits of their solutions.
Come discover SafetyEasy® Suite, a pre-validated, agile and compliant solution for global life science companies, integrating intelligent automation to streamline day-to-day activities, reduce manual effort and accelerate reporting processes for safety teams.
MedDRA
Medical Dictionary for Regulatory Activities
In the late 1990s, the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) developed MedDRA, a rich and highly specific standardized medical terminology to facilitate sharing of regulatory information internationally for medical products used by humans. ICH’s powerful tool, MedDRA is available to all for use in the registration, documentation and safety monitoring of medical products both before and after a product has been authorized for sale. Products covered by the scope of MedDRA include pharmaceuticals, biologics, vaccines and drug-device combination products. Today, its growing use worldwide by regulatory authorities, pharmaceutical companies, clinical research organizations and health care professionals allows better global protection of patient health.
The Maintenance and Support Services Organization (MSSO) was established by the (ICH) to manage the Medical Dictionary for Regulatory Activities (MedDRA) terminology. The MSSO serves as the repository, maintainer, and distributor of MedDRA. In this capacity, the MSSO ensures that the integrity of the terminology, as well as its medical correctness, stay intact. The MSSO has maintained the Terminology in a state of control since its receipt of the “Golden Master” version of the terminology and several supporting documents in December 1998. This Quality System Manual (QSM) for the MSSO defines and describes program management responsibilities and MedDRA maintenance and support organization process and product baselines for the MSSO. This QSM provides overarching guidance for the operation and maintenance of the MedDRA Maintenance Quality Management System (QMS).
Baupharma
Baupharma, headquartered in Prague, is a premier pharmaceutical service provider with over 25 years of industry experience. Our international team offers comprehensive services—including pharmacovigilance, regulatory affairs, medical writing, batch release and distribution, translations, and clinical research—across the EU, MENA region, CIS, Africa, USA, LATAM, and beyond. With offices in Czech Republic, Saudi Arabia, UAE and Egypt, we ensure efficient project management and collaboration, delivering tailored solutions that meet the unique needs of each market.
Baupharma Global presence
Email: [email protected]
Size: 50-100 employees
Since 2017
CEO: Ahmed Diaa Eldin; [email protected]
GM: Vojtech Svoboda; [email protected]
PharmaKnowl Consulting
PharmaKnowl Consulting is an SFDA-licensed Pharmacovigilance and Regulatory Affairs service provider. PharmaKnowl supports pharmaceutical, biotechnology, clinical research, and MedTech companies in achieving and maintaining compliance with Saudi Food and Drug Authority (SFDA) requirements.
Pharmacovigilance services include the appointment of licensed Saudi QPPV and Deputy QPPV, establishment and maintenance of local PV systems, development of regulatory documentation (PMSF, PSSF, SOPs), local literature monitoring, signal detection, and SFDA inspection readiness. Services also cover case intake, reconciliation, safety variation tracking, and regulatory intelligence updates, with full operational integration into global MAH systems.
In addition to pharmacovigilance, PharmaKnowl Consulting provides end-to-end regulatory support, including product registration, SFDA submission management, and licensing coordination, serving as a single point of contact for companies operating in the Saudi market.
With on-ground expertise and a structured, compliance-focused approach, PharmaKnowl ensures that all activities align with SFDA guidelines and international safety standards.
PharmaKnowl is an SFDA licensed, EU Audited, and ISO certified Pharmacovigilance Service Provider in Saudi Arabia.
PhV LATAM
PhV LATAM is a company that provides specialized services in pharmacovigilance, technovigilance, cosmetovigilance, regulatory affairs, and medical information.
PhV LATAM supports pharmaceutical companies and distributors in complying with local and international regulations through standardized processes and a multidisciplinary team.
The company is the first in LATAM region to be ISO 9001:2015 certified for pharmacovigilance services.
PhV LATAM offers operational coverage in Latin America, Africa, Asia, and the Middle East, with solutions tailored to the clients’ needs.
.
Qinecsa are redefining drug safety with our technology-enabled, end-to-end pharmacovigilance services, designed to help pharmaceutical companies stay ahead in an evolving regulatory landscape.
Baupharma
Baupharma, headquartered in Prague, is a premier pharmaceutical service provider with over 25 years of industry experience. Our international team offers comprehensive services—including pharmacovigilance, regulatory affairs, medical writing, batch release and distribution, translations, and clinical research—across the EU, MENA region, CIS, Africa, USA, LATAM, and beyond. With offices in Czech Republic, Saudi Arabia, UAE and Egypt, we ensure efficient project management and collaboration, delivering tailored solutions that meet the unique needs of each market.
Baupharma Global presence
Email: [email protected]
Size: 50-100 employees
Since 2017
CEO: Ahmed Diaa Eldin; [email protected]
GM: Vojtech Svoboda; [email protected]
Nextrove
Nextrove is a global consulting and technology firm with deep-rooted expertise in pharmacovigilance system optimization and safety operations.
With decades of experience in the Life Sciences sector, our team delivers end-to-end solutions across the entire safety chain from implementation, upgrades, cloud hosting and data migration to regulatory intelligence.
We provide full-service support for leading PV platforms including validated migrations and complex system integrations. Our proprietary Progressive Suite extends core safety systems with interoperable modules that enable automation, case intake optimization, and advanced reporting capabilities.
As a trusted partner to top pharmaceutical companies, CROs, and biotechs, we combine technical depth with industry expertise to drive digital transformation and operational excellence, empowering pharma to improve patient safety.
https://www.linkedin.com/company/nextrove/
.
Eu2P
Eu2P stands for “European program in Pharmacovigilance and Pharmacoepidemiology“. This consortium, coordinated by the university of Bordeaux, offers an innovative and academic web-based education & training offer in Pharmacovigilance and Pharmacoepidemiology at the worldwide level:
- An accredited Master of Science program :
This curriculum includes mandatory and optional course modules, possibly leading to a Master Specialisation Track - 32 individual accredited Certificates courses :
They can be attended on a single basis during the Master curriculum calendar - 91 individual Short courses :
They are bite-sized courses which have been designed out of the Master and Certificate modules’ course material and can be attended at anytime, any-pace.
Eu2P has recently been extended to the Am2P program dedicated to North American stakeholders in collaboration to the NaSOP chapter. Am2P also provides accredited postgraduate certificates and short courses in Pharmacovigilance and Pharmacoepidemiology and can be attended online at anytime, any-pace.
More info at www.eu2p.org and www.am2p-courses.com
Media Partners
Springer Nature
Springer Nature advances discovery by publishing robust and insightful research, supporting the development of new areas of knowledge, making ideas and information accessible around the world, and leading the way on open access.
Key to this is our ability to provide the best possible service to the whole research community.
Springer Nature’s catalog offers a wide range of products and services, including AdisInsight Safety which equips you with the essential tools to seamlessly manage your in-house PV literature monitoring. Our cutting-edge platform empowers you to efficiently monitor Individual Case Safety Reports (ICSRs) for adverse events and special situations. Plus, you can stay up to date with the latest drug safety news, ensuring that your PV processes remain robust and compliant. And what’s more important, AdisInsight Safety covers all pharmaceutical products.
You can rely on Springer Nature’s extensive knowledge and expertise, earned over 40 years as an industry leader. Our experience gives us a unique perspective on the challenges you face today, helping you see the world of drug development more clearly.
